These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 27021556

  • 1. Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
    Oh PC, Kang WC, Moon J, Park YM, Kim S, Kim MG, Lee K, Ahn T, Shin EK.
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):221-8. PubMed ID: 27021556
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of carvedilol and atenolol efficacy in patients with stable effort angina].
    Martsevich SIu, Koniakhina IP, Alimova EV, Kutishenko NP, Lerman OV.
    Ter Arkh; 2001 Jun; 73(1):38-41. PubMed ID: 11234138
    [Abstract] [Full Text] [Related]

  • 3. Carvedilol versus verapamil in chronic stable angina: a multicentre trial.
    Hauf-Zachariou U, Blackwood RA, Gunawardena KA, O'Donnell JG, Garnham S, Pfarr E.
    Eur J Clin Pharmacol; 1997 Jun; 52(2):95-100. PubMed ID: 9174677
    [Abstract] [Full Text] [Related]

  • 4. Comparison of carvedilol and atenolol for angina pectoris.
    Freedman SB, Jamal SM, Harris PJ, Kelly DT.
    Am J Cardiol; 1987 Sep 01; 60(7):499-502. PubMed ID: 2888302
    [Abstract] [Full Text] [Related]

  • 5. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
    Ruilope LM.
    Am J Hypertens; 1994 Feb 01; 7(2):129-36. PubMed ID: 7910028
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
    Giugliano D, Acampora R, Marfella R, De Rosa N, Ziccardi P, Ragone R, De Angelis L, D'Onofrio F.
    Ann Intern Med; 1997 Jun 15; 126(12):955-9. PubMed ID: 9182472
    [Abstract] [Full Text] [Related]

  • 8. Effects of a new vasodilating beta-blocking drug, carvedilol, on left ventricular function in stable angina pectoris.
    Lahiri A, Rodrigues EA, Al-Khawaja I, Raftery EB.
    Am J Cardiol; 1987 Apr 01; 59(8):769-74. PubMed ID: 2881480
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of carvedilol in mild to moderate essential hypertension and effects on microalbuminuria: a multicenter, randomized, open-label, controlled study versus atenolol.
    Marchi F, Ciriello G.
    Adv Ther; 1995 Apr 01; 12(4):212-21. PubMed ID: 10155349
    [Abstract] [Full Text] [Related]

  • 10. Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
    Widmann L, van der Does R, Hörrmann M, Machwirth M.
    Eur J Clin Pharmacol; 1990 Apr 01; 38 Suppl 2():S143-6. PubMed ID: 1974505
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris.
    Salonen JT, Taskinen E, Salonen R, Seppänen K, Venäläinen J, Rauramaa R.
    Am J Cardiol; 1986 Nov 26; 58(12):35E-40E. PubMed ID: 2878600
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.